secwatch.observer — SEC 8-K summary
======================================

Issuer:     Praxis Precision Medicines, Inc. (PRAX)
CIK:        0001689548
Form:       8-K
Filed at:   2025-09-05T23:59:59+00:00
Accession:  0001104659-25-087865
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Praxis terminates $250M Jefferies ATM, enters new $250M ATM with TD Cowen
-------------------------------------------------------------------------

- Terminated 2024 Sales Agreement with Jefferies effective Sept 2, 2025; no penalties.
- Previously sold 1,368,176 shares for ~$86.2M gross proceeds under that agreement.
- Entered new 2025 Sales Agreement with TD Cowen for up to $250M in at-the-market offerings.
- TD Cowen will receive a commission of up to 3.0% of gross proceeds from sales.
- New ATM will be made under existing S-3ASR registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689548/000110465925087865/0001104659-25-087865-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689548/000110465925087865/tm2525240d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-087865

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer